AG
CCXI

Advisor Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Advisor Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,920
Closed -$27K – 5515
2019
Q3 		$27K Sell
3,920
-712
-15% -$5.34K ﹤0.01% 3781
2019
Q2 		$43K Hold
4,632
– – ﹤0.01% 3490
2019
Q1 		$64K Sell
4,632
-718
-13% -$8.21K ﹤0.01% 3214
2018
Q4 		$58K Sell
5,350
-2,264
-30% -$23.9K ﹤0.01% 3081
2018
Q3 		$96K Buy
7,614
+3,814
+100% +$46K ﹤0.01% 2789
2018
Q2 		$51K Buy
3,800
+600
+19% +$7.18K ﹤0.01% 3096
2018
Q1 		$44K Buy
3,200
+200
+7% +$2.06K ﹤0.01% 3165
2017
Q4 		$18K Buy
+3,000
New +$20.6K ﹤0.01% 3785
2017
Q3 		– Sell
-1,500
Closed -$14K – 5000
2017
Q2 		$14K Buy
+1,500
New +$11K ﹤0.01% 3755

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Advisor Group's CCXI Position: Q4 2019 in Review

Advisor Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2019, closing a stake of 3,920 shares — an estimated $27K sold.

Advisor Group first reported a position in CCXI in Q2 2017 and held it in 9 quarters. The position peaked at $96K in Q3 2018. 126 funds tracked by Wall St. Rank hold CCXI as of Q4 2019.

  • Advisor Group reported no remaining ChemoCentryx, Inc. position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 3,920 ChemoCentryx, Inc. shares in Q4 2019, an estimated $27K.
  • Advisor Group first reported a position in ChemoCentryx, Inc. in Q2 2017 and held it in 9 quarters.
  • Advisor Group's ChemoCentryx, Inc. position peaked at $96K in Q3 2018.
  • 126 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.